Goldfarb Robert I 4
4 · NEXIEN BIOPHARMA, INC. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Goldfarb Robert I
Chief Operating Officer
Transactions
- Award
Common Stock
2022-10-17+250,000→ 1,528,800 total - Award
Options to purchase common stock (right to buy)
2020-08-19+1,000,000→ 1,000,000 totalExercise: $0.08From: 2020-08-19Exp: 2027-08-19→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]Issued in lieu of compensation for services.